Llovet JM, Brú C, Bruix J.Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329-38.

Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19.

Pons F, Varela M, Llovet JM. Staging systems in hepatocellular carcinoma. HPB : The Official Journal of the International Hepato Pancreato Biliary Association. 2005;7(1):35-41. doi:10.1080/13651820410024058.

Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol. 2004;40:124–31.

Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update.Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.

Dr. Josep Llovet

Barcelona-Clinic Liver Cancer (BCLC) Staging Classification and Treatment Guidelines

stage

numnodes

portalpressure

assocdis

<p>Determines progression of disease and proper treatment course for patients with HCC.</p>

Determines progression and treatment course in HCC,

BCLC Staging Classification

The BCLC Staging Classification determines progression of disease and proper treatment course for patients with HCC.

MELD Na (UNOS/OPTN)

Child-Pugh Score

mRECIST

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function